This page follows insider dealings at Filament Health Corp. as filed with SEDI. Between 23 October 2025 and 23 October 2026, 1 insider published 1 filing.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 2,640 companies) published 13 filings over the same period, against 1 filing here. Looking back to 2021, when coverage begins, insiders filed 18 purchases and no sales.
There has been no open-market purchase by an insider of Filament Health Corp. for at least a year.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 30 declarations
Filament Health Corp. is a company focused on developing plant-based health solutions. It is listed on the XTSE.